Pacira Biosciences Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$24.44

-1.05 (-4.12%)

As of May 9, 1:40 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 3 23%

Sell 1 8%

Price Target

Analyst Price Target -7.1% upside

Low Target $15.64

Average Target $22.71

High Target $35.67

Current Price $24.44

Current
$24.44

Target
$22.71

$15.64 $22.71 avg $35.67

Scenario Analysis

Bear Case

$15.64

-36.0%

Low target

Base Case

$22.71

-7.1%

Avg target

Bull Case

$35.67

+45.9%

High target

Risk/Reward

1.3x

Balanced

Price in Context

52-Week High

$27.64

-11.6% from high

52-Week Low

$18.80

+30.0% from low

Target vs 52W High

$22.71

-17.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%